Treatment of B-cell lymphoma with rituximab in two patients with Sjögren's syndrome associated with hepatitis C virus infection

scientific article published in January 2004

Treatment of B-cell lymphoma with rituximab in two patients with Sjögren's syndrome associated with hepatitis C virus infection is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1191/0961203304LU2049XX
P698PubMed publication ID15645755

P50authorManuel Ramos-casalsQ42646201
Ricard Cervera i SeguraQ53547424
Pilar Brito ZerónQ56956066
Josep FontQ73474655
Armando López-GuillermoQ88697793
P2093author name stringSS-HCV Study Group
P2860cites workRituximab therapy and autoimmune disorders: prospects for anti-B cell therapyQ33348384
Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunologic description of 35 casesQ34154745
Efficacy and safety of rituximab in type II mixed cryoglobulinemiaQ40566328
Hepatitis C virus infection, Sjögren's syndrome, and non-Hodgkin's lymphomaQ42995896
Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis.Q42996739
Infection and LymphomaQ43748639
F-18 FDG positron emission tomography demonstrates resolution of non-Hodgkin's lymphoma of the parotid gland in a patient with Sjogren's syndrome: before and after anti-CD20 antibody rituximab therapyQ43851581
P433issue12
P921main subjectSjögren's syndromeQ335555
rituximabQ412323
Hepatitis C virusQ708693
B-cell lymphomaQ4833719
P304page(s)969-971
P577publication date2004-01-01
P1433published inLupusQ6704846
P1476titleTreatment of B-cell lymphoma with rituximab in two patients with Sjögren's syndrome associated with hepatitis C virus infection
P478volume13

Reverse relations

cites work (P2860)
Q35948807'Les liaisons dangereuses': Hepatitis C, Rituximab and B-cell non-Hodgkin's lymphomas.
Q36951011Advances in lupus and Sjögren's syndrome: a tribute to Josep Font
Q56907510Chapter 16 Extrahepatic Manifestations in Patients with Chronic Hepatitis C Virus Infection
Q46757012Combined therapy with rituximab plus cyclophosphamide/vincristine/prednisone for Sjogren's syndrome-associated B-cell non-Hodgkin's lymphoma
Q35638676Consensus statement on the use of rituximab in patients with rheumatoid arthritis
Q42921901Controversies on rituximab therapy in sjögren syndrome-associated lymphoproliferation
Q36997278Conventional therapy of Sjogren's syndrome
Q37729176Emerging biotherapies for Sjögren's syndrome
Q35731058Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infection
Q34098553Hepatitis C virus-related lymphoproliferative disorders: an overview.
Q40238844New approaches in Sjögren's syndrome therapy
Q24644580Resistance to rituximab therapy and local BAFF overexpression in Sjögren's syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphoma
Q37366617Successful treatment of relapsing autoimmune pancreatitis in primary Sjögren's syndrome with rituximab: report of a case and review of the literature.
Q33372523Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome
Q36171750Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007

Search more.